Relmada Therapeutics Files 2024 Annual Report
Ticker: RLMD · Form: 10-K · Filed: Mar 27, 2025 · CIK: 1553643
| Field | Detail |
|---|---|
| Company | Relmada Therapeutics, Inc. (RLMD) |
| Form Type | 10-K |
| Filed Date | Mar 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, pharmaceuticals
TL;DR
Relmada Therapeutics filed its 2024 10-K. All systems go.
AI Summary
Relmada Therapeutics, Inc. filed its annual report for the fiscal year ended December 31, 2024. The company, formerly known as Camp Nine, Inc., is incorporated in Nevada and headquartered in Coral Gables, Florida. Its principal executive offices are located at 2222 Ponce de Leon Blvd., Floor 3, Coral Gables, FL 33134, with a business phone number of (786) 629-1376.
Why It Matters
This filing provides a comprehensive overview of Relmada Therapeutics' financial performance and business operations for the past fiscal year, offering insights for investors and stakeholders.
Risk Assessment
Risk Level: low — This is a standard annual report filing with no immediate red flags or significant new disclosures that would indicate elevated risk.
Key Players & Entities
- RELMADA THERAPEUTICS, INC. (company) — Filer
- 2024 (date) — Fiscal year end
- December 31 (date) — Fiscal year end
- Camp Nine, Inc. (company) — Former company name
- Nevada (jurisdiction) — State of incorporation
- 2222 Ponce de Leon Blvd., Floor 3 (address) — Principal executive offices
- Coral Gables (location) — City of principal executive offices
- FL (location) — State of principal executive offices
- 33134 (zip_code) — Zip code of principal executive offices
- (786) 629-1376 (phone_number) — Registrant's telephone number
FAQ
What is the company's primary business?
The company's Standard Industrial Classification is 'PHARMACEUTICAL PREPARATIONS [2834]', indicating its primary business is in the pharmaceutical sector.
When was the company incorporated?
The company was incorporated in Nevada.
What was the previous name of Relmada Therapeutics, Inc.?
The company was formerly known as Camp Nine, Inc.
Where are Relmada Therapeutics' principal executive offices located?
The principal executive offices are located at 2222 Ponce de Leon Blvd., Floor 3, Coral Gables, FL 33134.
What is the SEC file number for Relmada Therapeutics?
The Commission file number for Relmada Therapeutics is 000-55347.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 27, 2025 regarding RELMADA THERAPEUTICS, INC. (RLMD).